Literature DB >> 28409676

Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.

Nianmin Shi1, Qiang Lu1, Jiao Zhang1, Li Li1, Junnan Zhang1, Fanglei Zhang1, Yanhong Dong1, Xinyue Zhang1, Zheng Zhang1, Wenhui Gao1.   

Abstract

OBJECTIVE: This study aims to prevent persistentinfection, reduce the incidence of cervical cancer, and improve women's health by understanding the theoretical basis of the risk factors for continuous infection of asymptomatic women with high-risk human papilloma virus (HPV) strains via information collected, which includes the persistent infection rate and the most prevalent HPV strain types of high risk to asymptomatic women in the high-risk area of cervical cancer in Linfen, Shanxi Province.
METHODS: Based on the method of cluster sampling, locations were chosen from the industrial county and agricultural county of Linfen, Shanxi Province, namely the Xiangfen and Quwo counties. Use of the convenience sampling (CS) method enables the identification of women who have sex but without symptoms of abnormal cervix for analyzing risk factors of HPV-DNA detection and performing a retrospective questionnaire survey in these 2 counties. Firstly, cervical exfoliated cell samples were collected for thin-layer liquid-based cytology test (TCT), and simultaneously testing high-risk type HPV DNA, then samples with positive testing results were retested to identify the infected HPV types. The 6-month period of testing was done to derive the 6-month persistent infection rate. The retrospective survey included concepts addressed in the questionnaire: basic situation of the research objects, menstrual history, marital status, pregnancy history, sexual habits and other aspects. The questionnaire was divided into a case group and a comparison group, which are based on the high-risk HPV-DNA testing result to ascertain whether or not there is persistent infection. Statistical analysis employed Epidate3.1 software for date entry, SPSS17.0 for date statistical analysis. Select statistic charts, Chi-Square Analysis, single-factor analysis and multivariate Logistic regression analysis to analyze the protective factors and risk factors of high-risk HPV infection. Risk factors are predicted by using the classification tree.
RESULTS: 3000 women participated in the study. The high-risk type HPV infection rate was 8.7%, the persistent infection rate was 7.5%. The persistent infection rates for the 2 age groups (ages 18-26 and 27-30) were 6.9% and 8.7%. The persistent infection rates of Xiangfen county were 7.4% and 7.4% respectively, and those of Quwo county were 7.8% and 11.6% respectively; there was no significant difference between each pair of groups. Single risk-factor analysis showed that first-time sex at age under 20, high school/technical secondary school education or above, multiple sexual partners, having more than 2 sexual partners in the past 6 months, oral sex, and colitis are the risk factors of high-risk type HPV infection. Multivariate analysis showed that the number of sexual partners, smoking and oral sex had an effect on HPV infection. The risk of HPV infection from smoking was 5.0-fold higher, and the risk of HPV infection from oral sex was 6.1-fold higher. Having more than 2 sexual partners increase the risk of HPV infection. By the predicated model analysis, the probability of HPV conveyed by oral sex was 14.8%; if the sexual companion number was zero or more than 2 without oral sex, the probability of HPV infection was 12.1%; if there was one sexual partner who smokes without oral sex, the probability of infection was 18.6%; if there was one sexual partner who does not smoke and without oral sex, the probability of infection was 3.6%.
CONCLUSION: The persistent infection rate of asymptomatic women for high-risk type HPV is lower than those women in all ages. High-risk type HPV infection risk factors include the number of sexual partners, oral sex and smoking. Thus, young women may be able to reduce the risk of infection with high-risk type HPV by reducing the number of sexual partners, forming a correct sexual life habit, and avoiding smoking.

Entities:  

Keywords:  asymptomatic women; human papilloma virus; influence factors; persistent infection

Mesh:

Substances:

Year:  2017        PMID: 28409676      PMCID: PMC5524175          DOI: 10.1080/21645515.2016.1239669

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  10 in total

1.  HPV and cervical cancer in the 2007 report.

Authors: 
Journal:  Vaccine       Date:  2007-11-01       Impact factor: 3.641

Review 2.  Papillomavirus infections and human genital cancer.

Authors:  H zur Hausen; E M de Villiers; L Gissmann
Journal:  Gynecol Oncol       Date:  1981-10       Impact factor: 5.482

3.  Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.

Authors:  Gypsyamber D'Souza; Neil D Gross; Sara I Pai; Robert Haddad; Karen S Anderson; Shirani Rajan; Jennifer Gerber; Maura L Gillison; Marshall R Posner
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

4.  Evidence of Epstein-Barr virus in lymphoepithelioma-like carcinoma of the uterine cervix: a case report.

Authors:  L H Tseng; C J Tseng; Y K Soong; S Hsueh; C C Pao
Journal:  Changgeng Yi Xue Za Zhi       Date:  1998-06

Review 5.  Epidemiology of HPV-associated oropharyngeal cancer.

Authors:  Kristen B Pytynia; Kristina R Dahlstrom; Erich M Sturgis
Journal:  Oral Oncol       Date:  2014-01-22       Impact factor: 5.337

Review 6.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

Authors:  Silvia de Sanjosé; Mireia Diaz; Xavier Castellsagué; Gary Clifford; Laia Bruni; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Infect Dis       Date:  2007-07       Impact factor: 25.071

7.  [The role of human papillomavirus (HPV) infection in the pathogenesis of the laryngeal cancer].

Authors:  W Makowska
Journal:  Otolaryngol Pol       Date:  1998

8.  Clearance of HPV infection in middle aged men and women after 9 years' follow up.

Authors:  S de Sanjose; F X Bosch; L A Tafur; C M Nascimento; I Izarzugaza; A Izquierdo; A Barricarte; K V Shah; C J L M Meijer; N Muñoz
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

9.  Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.

Authors:  Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Francis P Worden; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Carol R Bradford; Thomas E Carey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

10.  Human papillomavirus infection in Beijing, People's Republic of China: a population-based study.

Authors:  R Zhao; W Y Zhang; M H Wu; S W Zhang; J Pan; L Zhu; Y P Zhang; H Li; Y S Gu; X Z Liu
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

  10 in total
  4 in total

1.  Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.

Authors:  Jing Yang; Wei Wang; Zhe Wang; Zhilian Wang; Yonghong Wang; Jintao Wang; Weihong Zhao; Dongyan Li; Huiqiang Liu; Min Hao
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

2.  Expression of p16INK4a and human papillomavirus 16 with associated risk factors in cervical premalignant and malignant lesions.

Authors:  Abha Pandey; Smita Chandra; Ruchira Nautiyal; Vikas Shrivastav
Journal:  South Asian J Cancer       Date:  2018 Oct-Dec

3.  Status and epidemiological characteristics of high-risk human papillomavirus infection in multiple centers in Shenyang.

Authors:  Di Yang; Jing Zhang; Xiaoli Cui; Jian Ma; Chunyan Wang; Haozhe Piao
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

4.  Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.

Authors:  Masoumeh Abdolmaleki; Amir Sohrabi
Journal:  J Cancer Prev       Date:  2018-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.